# Inner Medical Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/inner-medical-co

- Industry: Medical Devices & Equipment
- Headquarters: Shenzhen, China
- Website: www.innermed.com
- Total disclosed funding: $43M
- Latest round: Series D (Feb 6, 2023)
- Investors on record: 20

## About

Based in Shenzhen, China, and established in 2015, Inner Medical Co., Ltd operates as a diagnostic and therapeutic solution provider that provides the diagnosis and treatment options of gastrointestinal and respiratory tract tumors and cardiovascular diseases. The company has production bases located in Pingshan and Shiyan, nearly 8,000 square feet of R&D space and has offices located in Beijing, Chengdu and Xi'an. It has applied more than 200 patents. In August 2016, Inner Medical Co., Ltd established cardiovascular technology platform. In August 2022, it promoted medical image processing software. In September 2024, Inner Medical Co., Ltd closed a venture funding from new investor Shenzhen Guozhong Venture Capital.

Inner Medical Co., Ltd provides the diagnosis and treatment options of gastrointestinal and respiratory tract tumours and cardiovascular diseases. Specific products include diagnostic ultrasound equipment for endoscopy, full HD electronic endoscopes, the first dual-frequency ultrasound endoscopes, respiratory ultrasound endoscopes and dual-mode imaging systems. The company also provides diagnosis and treatment of various diseases of the digestive system. Its technology platform includes ultrasound electronics, optical technology, energy technology and interventional devices.

The company generates revenue by providing catheter imaging equipment for diagnosis and treatment of cardiovascular, digestive, respiratory and other cavities in the human body.

## Funding rounds

- Series D, Feb 6, 2023 — Midas Capital, Sutou Equity
- Series D, Dec 18, 2022, $43M — Green Pine Capital Partners, CoStone Capital, Huatai Zijin Investment, Minsheng Equity Investment, Shenzhen Longgang Financial Investment Holdings, Dice Investments, Simiao Capital, Chengshang Investment, Hunan Light Salt Shengfu Venture Capital Management
- Series C, Apr 30, 2021 — Shenzhen HTI, Efung Capital, Sangel Capital, China Science and Tech Innovation Venture Capital, Guiyang Venture Capital
- Series A, Jul 16, 2020 — Efung Capital, Shenzhen Guozhong Venture Capital, Guiyang Venture Capital, Pengnian Venture Capital
- Series A, Jan 2, 2019 — Shenzhen Guozhong Venture Capital, Maliang Capital, Shenzhen High-tech Investment&Guaranty Co., Ltd.
- Angel, Apr 20, 2016 — Sangel Capital

## Investors

- Sangel Capital (https://capitalatlas.ai/funds/sangel-capital) — Angel, Series C
- Shenzhen Guozhong Venture Capital (https://capitalatlas.ai/funds/shenzhen-guozhong-venture-capital) — Series A
- Maliang Capital — Series A
- Shenzhen High-tech Investment&Guaranty Co., Ltd. — Series A
- Efung Capital (https://capitalatlas.ai/funds/efung-capital) — Series A, Series C
- Guiyang Venture Capital (https://capitalatlas.ai/funds/guiyang-venture-capital) — Series A, Series C
- Pengnian Venture Capital (https://capitalatlas.ai/funds/pengnian-venture-capital) — Series A
- Shenzhen HTI (https://capitalatlas.ai/funds/shenzhen-hti) — Series C
- China Science and Tech Innovation Venture Capital (https://capitalatlas.ai/funds/china-science-and-tech-innovation-venture-capital) — Series C
- Green Pine Capital Partners (https://capitalatlas.ai/funds/green-pine-capital-partners) — Series D
- CoStone Capital (https://capitalatlas.ai/funds/costone-capital) — Series D
- Huatai Zijin Investment (https://capitalatlas.ai/funds/huatai-zijin-investment) — Series D
- Minsheng Equity Investment (https://capitalatlas.ai/funds/minsheng-equity-investment) — Series D
- Shenzhen Longgang Financial Investment Holdings (https://capitalatlas.ai/funds/shenzhen-longgang-financial-investment-holdings) — Series D
- Dice Investments — Series D
- Simiao Capital (https://capitalatlas.ai/funds/simiao-capital) — Series D
- Chengshang Investment — Series D
- Hunan Light Salt Shengfu Venture Capital Management — Series D
- Midas Capital — Series D
- Sutou Equity — Series D